Skip to main navigation
Treatments for the Advancement of Life
  Menu
  • Home
  • About Us
    • Company Profile
    • Board of Directors
    • Management
    • Contact Us
  • Pipeline
    • Azeliragon
    • TTP399
    • TTP273
    • HPP593
    • HPP737
    • Nrf2/Bach1 Program
    • Expanded Access
  • Technology
  • News
    • Press Releases
    • Publications
  • Investors

    Investor Relations

    • Investor Overview
    • Stock Information
    • Financial Information
    • News & Events
    • Corporate Governance
    • Shareholder Services

Investor Relations

  • Investor Overview
  • Stock Information
  • Financial Information
  • News & Events
  • Corporate Governance
  • Shareholder Services

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Share Page
  • E-mail Alerts
  • IR Contacts
X
  • Share on:
  • E-mail
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Reddit
  • Digg
  • Google
  • Delicious
  • StumbleUpon

SEC Filing Details

Document Details

Form
SC 13D/A
Filing Date
Nov 26, 2019
Document Date
Nov 26, 2019
Form Description
An amendment to a SC 13D filing
Filing Group
3,4,5
Company
vTv Therapeutics Inc.
Issuer
vTv Therapeutics Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Information

  • Pipeline
  • Management

Location

  • Contact Us

About vTv

  • About Company

(c) Copyright 2019 VTV Therapeutics. Designed by vTv Therapeutics.